Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2530402

C=CC(=O)OCCC[N+](CC)(CC)CC.[Cl-]

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 1/20 0.33
CHRM1 known ✓ P11229 1/20 0.33
CHRM3 known ✓ P20309 1/20 0.33
TSHR P16473 8/20 0.61
HPGD P15428 1/20 0.61
ALDH1A1 P00352 4/20 0.57
CYP3A4 P08684 2/20 0.57
TP53 P04637 3/20 0.47
HIF1A Q16665 3/20 0.47
HSD17B10 Q99714 1/20 0.47
THRB P10828 2/20 0.44
ATM Q13315 1/20 0.41
HCAR2 Q8TDS4 3/20 0.37
MAPK1 P28482 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
DNM1 Q05193 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10882384 0.98 TSHR (0.63) TSHRHPGDALDH1A1CYP3A4TP53
Bromide SCHEMBL130775 0.96 TSHR (0.61) TSHRHPGDALDH1A1CYP3A4TP53
SCHEMBL28739964 0.91 TSHR (0.66) TSHRHPGDALDH1A1CYP3A4TP53
Bromide SCHEMBL17957152 0.90 TSHR (0.63) TSHRHPGDALDH1A1CYP3A4TP53
Hydrochloric Acid SCHEMBL475768 0.89 TSHR (0.55) TSHRHPGDALDH1A1CYP3A4TP53
Hydrochloric Acid SCHEMBL30734089 0.88 TSHR (0.70) TSHRHPGDALDH1A1CYP3A4TP53
SCHEMBL1476239 0.87 TSHR (0.57) TSHRHPGDALDH1A1CYP3A4TP53
SCHEMBL13415756 0.86 TSHR (0.67) TSHRHPGDALDH1A1CYP3A4TP53
Bromide SCHEMBL11522116 0.85 TSHR (0.55) TSHRHPGDALDH1A1CYP3A4TP53
Hydrochloric Acid SCHEMBL5239242 0.84 TSHR (0.59) TSHRHPGDALDH1A1CYP3A4TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570860-B2 Two-component treatment agent, treatment method for making metal surface antibacterial and antibacterial treatment agent TOKYO OHKA KOGYO CO., LTD. (JP) 2026-03-10 US disclosed
US-20220267615-A1 TWO-COMPONENT TREATMENT AGENT, TREATMENT METHOD FOR MAKING METAL SURFACE ANTIBACTERIAL AND ANTIBACTERIAL TREATMENT AGENT TOKYO OHKA KOGYO CO., LTD. (JP) 2022-08-25 US disclosed
US-20120202959-A1 Process for Producing Water-Absorbing Polymer Particles BASF SE (DE) 2012-08-09 US disclosed
US-20110257340-A1 Process for Producing Water-Absorbing Polymer Particles BASF SE (DE) 2011-10-20 US disclosed
US-20040232262-A1 Process for producing aqueous pigment dispersion and aqueous pigment dispersion obtained by the process SAKATA INX CORP. (JP) 2004-11-25 US disclosed
EP-1418210-A1 PROCESS FOR PRODUCING AQUEOUS PIGMENT DISPERSION AND AQUEOUS PIGMENT DISPERSION OBTAINED BY THE PROCESS Sakata Inx Corporation (JP) 2004-05-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570860-B2 Two-component treatment agent, treatment method for making metal surface antibacterial and antibacterial treatment agent SARS1, ACE2, EIF2AK2 CHRM2 3596/4885CHRM1 2671/4885CHRM3 3038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.